Chemoradiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study.
AuthorsHenry, Ann M
Ryder, W David J
Moore, Christopher J
Sherlock, David J
Geh, J I
Price, Patricia M
AffiliationAcademic Department of Radiation Oncology, The University of Manchester, Department of Medical Statistics, Christie Hospital NHS Trust, Manchester, UK.
MetadataShow full item record
AbstractAIMS: To determine the efficacy of radiation dose escalation and to examine organ motion during conformal radiotherapy for locally advanced pancreatic cancer. MATERIALS AND METHODS: Thirty-nine patients who were consecutively treated with chemoradiotherapy were studied. Fifteen patients, treated from 1993 to 1997, received 50 Gy in 20 fractions (group I). Twenty-four patients, treated from 1997 to 2003, received an escalated dose of 55 Gy in 25 fractions (group II). Intra-fraction pancreatic tumour motion was assessed in three patients using megavoltage movies during radiation delivery to track implanted radio-opaque markers. RESULTS: Improved survival rates were seen in latterly treated group II patients (P=0.083), who received escalated radiotherapy to smaller treatment volumes due to advances in verification. Worse toxicity effects (World Health Organization grade 3-4) were reported by some patients (<10%), but treatment compliance was similar in both groups, indicating equivalent tolerance. Substantial intra-fraction tumour displacement due to respiratory motion was observed: this was greatest in the superior/inferior (mean=6.6 mm) and anterior/posterior (mean=4.75 mm) directions. Lateral displacements were small (<2 mm). CONCLUSIONS: Dose escalation is feasible in pancreatic cancer, particularly when combined with a reduction in irradiated volume, and enhanced efficacy is indicated. Large, globally applied margins to compensate for pancreatic tumour motion during radiotherapy may be inappropriate. Strategies to reduce respiratory motion, and/or the application of image-guided techniques that incorporate individual patients' respiratory motion into radiotherapy planning and delivery, will probably improve pancreatic radiotherapy.
CitationChemoradiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study. 2008, 20 (7):541-7 Clin Oncol
- Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer.
- Authors: Gwynne S, Wills L, Joseph G, John G, Staffurth J, Hurt C, Mukherjee S
- Issue date: 2009 Nov
- Intraoperative and conformal external-beam radiation therapy in patients with locally advanced pancreatic carcinoma; results from a feasibility phase II study.
- Authors: Furuse J, Ogino T, Ryu M, Kinoshita T, Konishi M, Kawano N, Ishikura S, Shimizu W, Sekiguchi R, Moriyama N, Iwasaki M, Yoshino M
- Issue date: 2000 Jul-Aug
- Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer.
- Authors: Gunnlaugsson A, Kjellén E, Nilsson P, Bendahl PO, Willner J, Johnsson A
- Issue date: 2007
- Therapeutic effect of three-dimensional conformal radiotherapy on locally advanced pancreatic carcinoma.
- Authors: Shi YS, Xu SJ, Zheng XK, Yan WP, Chen LH
- Issue date: 2004 Feb
- Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer.
- Authors: Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA
- Issue date: 2004 Mar 15